ARK Investment Management - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q4 2021$107,164,000
-51.5%
7,862,379
-41.8%
0.32%
-39.0%
Q3 2021$221,157,000
-15.2%
13,501,650
-12.9%
0.53%
+9.5%
Q2 2021$260,747,000
-23.7%
15,492,997
-17.2%
0.48%
-28.6%
Q1 2021$341,775,000
+117.9%
18,717,144
+117.2%
0.68%
+62.8%
Q4 2020$156,851,000
+660.4%
8,618,165
+645.3%
0.42%
+241.8%
Q3 2020$20,628,0001,156,2970.12%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Adelphi Capital LLP 7,931,116$140,381,00032.92%
Endurant Capital Management LP 932,967$16,514,0006.51%
Glenview Capital Management 26,430,828$467,826,0004.24%
Paulson & Co. 13,244,711$234,431,0003.98%
Blackcrane Capital, LLC 172,955$3,061,0003.88%
NINE MASTS CAPITAL Ltd 1,474,286$26,146,0003.74%
Velanne Asset Management Ltd 286,640$5,074,0003.22%
LMR Partners LLP 4,563,591$80,884,0002.95%
SECTOR GAMMA AS 796,299$14,094,0002.26%
MFN Partners Management, LP 785,000$13,895,0002.21%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders